Molecular events in the jawvascular unit: A traditional review of the mechanisms involved in inflammatory jaw bone diseases

Ruyu Wang; Haoran Wang; Junyu Mu; Hua Yuan; Yongchu Pang; Yuli Wang; Yifei Du; Feng Han

doi:10.7555/JBR.36.20220266

Article Contents

Article Navigation > The Journal of Biomedical Research > 2019 > Online Publication

Ruyu Wang, Haoran Wang, Junyu Mu, Hua Yuan, Yongchu Pang, Yuli Wang, Yifei Du, Feng Han. Molecular events in the jawvascular unit: A traditional review of the mechanisms involved in inflammatory jaw bone diseases[J]. The Journal of Biomedical Research. doi: 10.7555/JBR.36.20220266

Citation:

Ruyu Wang, Haoran Wang, Junyu Mu, Hua Yuan, Yongchu Pang, Yuli Wang, Yifei Du, Feng Han. Molecular events in the jawvascular unit: A traditional review of the mechanisms involved in inflammatory jaw bone diseases[J]. The Journal of Biomedical Research. doi: 10.7555/JBR.36.20220266

Citation:

Ruyu Wang, Haoran Wang, Junyu Mu, Hua Yuan, Yongchu Pang, Yuli Wang, Yifei Du, Feng Han. Molecular events in the jawvascular unit: A traditional review of the mechanisms involved in inflammatory jaw bone diseases[J]. The Journal of Biomedical Research. doi: 10.7555/JBR.36.20220266

PDF( 5375 KB)

Molecular events in the jawvascular unit: A traditional review of the mechanisms involved in inflammatory jaw bone diseases

doi: 10.7555/JBR.36.20220266

Ruyu Wang^{1, 2, 3},
Haoran Wang^{1, 2, 3},
Junyu Mu⁴,
Hua Yuan^{1, 2, 3},
Yongchu Pang^{2, 3, 5},
Yuli Wang^{1, 2, 3
,
,},
Yifei Du^{1, 2, 3},
Feng Han^{4
,
,}

1.
Department of Oral and Maxillofacial Surgery, the Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China
2.
Jiangsu Province Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, Jiangsu 210029, China
3.
Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, Jiangsu 210029, China
4.
International Joint Laboratory for Drug Target of Critical Illnesses, Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China
5.
Department of Orthodontics, the Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China

More Information

Corresponding author: Yuli Wang and Yifei Du, Department of Oral and Maxillofacial Surgery, the Affiliated Stomatological Hospital of Nanjing Medical University, 1 Shanghai Road, Gulou District, Nanjing, Jiangsu 210029, China. Tel: +86-25-69593361 and +86-25-69593372, E-mails: njykdwyl@njmu.edu.cn and dyf@njmu.edu.cn; Feng Han, International Joint Laboratory for Drug Target of Critical Illnesses, Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, 101 Longmian Avenue, Jiangning District, Nanjing, Jiangsu 211166, China. Tel: +86-25-86868462, E-mail: fenghan169@njmu.edu.cn
Received: 2022-12-27
Revised: 2023-02-28
Accepted: 2023-03-08

Published: 2023-04-28

Abstract

Abstract

Inflammatory jaw bone diseases are common in stomatology, including periodontitis, peri-implantitis, medication-related osteonecrosis of the jaw, radiation osteomyelitis of the jaw, age-related osteoporosis, and other specific infections. These diseases may lead to tooth loss and maxillofacial deformities, severely affecting patients' quality of life. Over the years, the reconstruction of jaw bone deficiency caused by inflammatory diseases has emerged as a medical and socioeconomic challenge. Therefore, exploring the pathogenesis of inflammatory diseases associated with jaw bones is crucial for improving prognosis and developing new targeted therapies. Accumulating evidence indicates that the integrated bone formation and dysfunction arise from complex interactions among a network of multiple cell types, including osteoblast-associated cells, immune cells, blood vessels, and lymphatic vessels. However, the role of these different cells in the inflammatory process and the 'rules' with which they interact are still not fully understood. Although many investigations have focused on specific pathological processes and molecular events in inflammatory jaw diseases, few articles offer a perspective of integration. Here, we review the changes and mechanisms of various cell types in inflammatory jaw diseases, with the hope of providing insights to drive further research in this field.
- inflammatory diseases,
- osteogenesis-related cells,
- immune cells,
- blood vessels,
- lymphatic vessels,
- jawvascular unit

CLC number: R782, Document code: A
The authors reported no conflict of interests.

FullText(HTML)

References(117)

References

[1]	Kassebaum NJ, Bernabé E, Dahiya M, et al. Global burden of severe periodontitis in 1990–2010: a systematic review and meta-regression[J]. J Dent Res, 2014, 93(11): 1045–1053. doi: 10.1177/0022034514552491
[2]	Slots J. Primer on etiology and treatment of progressive/severe periodontitis: a systemic health perspective[J]. Periodontol 2000, 2020, 83(1): 272–276. doi: 10.1111/prd.12325
[3]	Lang NP, Berglundh T. Periimplant diseases: where are we now?--Consensus of the seventh european workshop on periodontology[J]. J Clin Periodontol, 2011, 38(Suppl 11): 178–181. doi: 10.1111/j.1600-051X.2010.01674.x
[4]	Yan R, Jiang R, Hu L, et al. Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)[J]. Int J Oral Sci, 2022, 14(1): 41. doi: 10.1038/s41368-022-00182-4
[5]	Gaudet C, Odet S, Meyer C, et al. Reporting criteria for clinical trials on medication-related osteonecrosis of the jaw (MRONJ): a review and recommendations[J]. Cells, 2022, 11(24): 4097. doi: 10.3390/cells11244097
[6]	Aminoshariae A, Donaldson M, Horan M, et al. Emerging antiresorptive medications and their potential implications for dental surgeries[J]. J Am Dent Assoc, 2022, 153(7): 649–658. doi: 10.1016/j.adaj.2021.12.008
[7]	Fusco V, Santini D, Armento G, et al. Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology[J]. Expert Opin Drug Saf, 2016, 15(7): 925–935. doi: 10.1080/14740338.2016.1177021
[8]	AlRowis R, Aldawood A, AlOtaibi M, et al. Medication-related osteonecrosis of the jaw (MRONJ): a review of pathophysiology, risk factors, preventive measures and treatment strategies[J]. Saudi Dent J, 2022, 34(3): 202–210. doi: 10.1016/j.sdentj.2022.01.003
[9]	Chen H, Liu Z, Yue K, et al. Immune microenvironment: novel perspectives on bone regeneration disorder in osteoradionecrosis of the jaws[J]. Cell Tissue Res, 2023, doi: 10.1007/s00441-023-03743-z. [Epub ahead of print].
[10]	Singh A, Kitpanit S, Neal B, et al. Osteoradionecrosis of the jaw following proton radiation therapy for patients with head and neck cancer[J]. JAMA Otolaryngol Head Neck Surg, 2023, 149(2): 151–159. doi: 10.1001/jamaoto.2022.4165
[11]	Kitaura H, Marahleh A, Ohori F, et al. Osteocyte-related cytokines regulate osteoclast formation and bone resorption[J]. Int J Mol Sci, 2020, 21(14): 5169. doi: 10.3390/ijms21145169
[12]	Almubarak A, Tanagala KKK, Papapanou PN, et al. Disruption of monocyte and macrophage homeostasis in periodontitis[J]. Front Immunol, 2020, 11: 330. doi: 10.3389/fimmu.2020.00330
[13]	Reddy LVK, Murugan D, Mullick M, et al. Recent approaches for angiogenesis in search of successful tissue engineering and regeneration[J]. Curr Stem Cell Res Ther, 2020, 15(2): 111–134. doi: 10.2174/1574888X14666191104151928
[14]	Mkonyi LE, Bakken V, Søvik JB, et al. Lymphangiogenesis is induced during development of periodontal disease[J]. J Dent Res, 2012, 91(1): 71–77. doi: 10.1177/0022034511424747
[15]	Yang N, Liu Y. The role of the immune microenvironment in bone regeneration[J]. Int J Med Sci, 2021, 18(16): 3697–3707. doi: 10.7150/ijms.61080
[16]	Csaki C, Matis U, Mobasheri A, et al. Co-culture of canine mesenchymal stem cells with primary bone-derived osteoblasts promotes osteogenic differentiation[J]. Histochem Cell Biol, 2009, 131(2): 251–266. doi: 10.1007/s00418-008-0524-6
[17]	Udagawa N, Takahashi N, Yasuda H, et al. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function[J]. Endocrinology, 2000, 141(9): 3478–3484. doi: 10.1210/endo.141.9.7634
[18]	Lee JH, Choi YJ, Heo SH, et al. Tumor necrosis factor-α converting enzyme (TACE) increases RANKL expression in osteoblasts and serves as a potential biomarker of periodontitis[J]. BMB Rep, 2011, 44(7): 473–477. doi: 10.5483/BMBRep.2011.44.7.473
[19]	Hayashi M, Nakashima T, Taniguchi M, et al. Osteoprotection by semaphorin 3A[J]. Nature, 2012, 485(7396): 69–74. doi: 10.1038/nature11000
[20]	Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation[J]. Cell, 1998, 93(2): 165–176. doi: 10.1016/S0092-8674(00)81569-X
[21]	Arai F, Miyamoto T, Ohneda O, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of C-Fms and receptor activator of nuclear factor κB (RANK) receptors[J]. J Exp Med, 1999, 190(12): 1741–1754. doi: 10.1084/jem.190.12.1741
[22]	Engelmann J, Zarrer J, Gensch V, et al. Regulation of bone homeostasis by MERTK and TYRO3[J]. Nat Commun, 2022, 13(1): 7689. doi: 10.1038/s41467-022-33938-x
[23]	Wu M, Chen W, Lu Y, et al. Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway[J]. Nat Commun, 2017, 8: 13700. doi: 10.1038/ncomms13700
[24]	Khotib J, Gani MA, Budiatin AS, et al. Signaling pathway and transcriptional regulation in osteoblasts during bone healing: direct involvement of hydroxyapatite as a biomaterial[J]. Pharmaceuticals (Basel), 2021, 14(7): 615. doi: 10.3390/ph14070615
[25]	Chen M, Cai W, Zhao S, et al. Oxidative stress-related biomarkers in saliva and gingival crevicular fluid associated with chronic periodontitis: a systematic review and meta-analysis[J]. J Clin Periodontol, 2019, 46(6): 608–622. doi: 10.1111/jcpe.13112
[26]	Xu Z, Wang X, Xiao D, et al. Hydrogen sulfide protects MC3T3-E1 osteoblastic cells against H2O2-induced oxidative damage-implications for the treatment of osteoporosis[J]. Free Radic Biol Med, 2011, 50(10): 1314–1323. doi: 10.1016/j.freeradbiomed.2011.02.016
[27]	El-Sayed KMF, Elahmady M, Adawi Z, et al. The periodontal stem/progenitor cell inflammatory-regenerative cross talk: a new perspective[J]. J Periodontal Res, 2019, 54(2): 81–94. doi: 10.1111/jre.12616
[28]	Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges[J]. Cell Stem Cell, 2015, 17(1): 11–22. doi: 10.1016/j.stem.2015.06.007
[29]	Capulli M, Paone R, Rucci N. Osteoblast and osteocyte: games without frontiers[J]. Arch Biochem Biophys, 2014, 561: 3–12. doi: 10.1016/j.abb.2014.05.003
[30]	Ling L, Nurcombe V, Cool SM. Wnt signaling controls the fate of mesenchymal stem cells[J]. Gene, 2009, 433: 1–7. doi: 10.1016/j.gene.2008.12.008
[31]	Wen Y, Yang H, Wu J, et al. COL4A2 in the tissue-specific extracellular matrix plays important role on osteogenic differentiation of periodontal ligament stem cells[J]. Theranostics, 2019, 9(15): 4265–4286. doi: 10.7150/thno.35914
[32]	Kawai T, Katagiri W, Osugi M, et al. Secretomes from bone marrow-derived mesenchymal stromal cells enhance periodontal tissue regeneration[J]. Cytotherapy, 2015, 17(4): 369–381. doi: 10.1016/j.jcyt.2014.11.009
[33]	Katagiri W, Watanabe J, Toyama N, et al. Clinical study of bone regeneration by conditioned medium from mesenchymal stem cells after maxillary sinus floor elevation[J]. Implant Dent, 2017, 26(4): 607–612. doi: 10.1097/ID.0000000000000618
[34]	Katagiri W, Osugi M, Kawai T, et al. First-in-human study and clinical case reports of the alveolar bone regeneration with the secretome from human mesenchymal stem cells[J]. Head Face Med, 2016, 12: 5. doi: 10.1186/s13005-016-0101-5
[35]	Huang Y, Zhang X, Zhan J, et al. Bone marrow mesenchymal stem cell-derived exosomal miR-206 promotes osteoblast proliferation and differentiation in osteoarthritis by reducing Elf3[J]. J Cell Mol Med, 2021, 25(16): 7734–7745. doi: 10.1111/jcmm.16654
[36]	Chew JRJ, Chuah SJ, Teo KYW, et al. Mesenchymal stem cell exosomes enhance periodontal ligament cell functions and promote periodontal regeneration[J]. Acta Biomater, 2019, 89: 252–264. doi: 10.1016/j.actbio.2019.03.021
[37]	Kang MS, Moon JH, Park SC, et al. Spirulina maxima reduces inflammation and alveolar bone loss in Porphyromonas gingivalis-induced periodontitis[J]. Phytomedicine, 2021, 81: 153420. doi: 10.1016/j.phymed.2020.153420
[38]	Inada M, Yasui T, Nomura S, et al. Maturational disturbance of chondrocytes in Cbfa1-deficient mice[J]. Dev Dyn, 1999, 214(4): 279–290. doi: 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W
[39]	Maruyama Z, Yoshida CA, Furuichi T, et al. Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency[J]. Dev Dyn, 2007, 236(7): 1876–1890. doi: 10.1002/dvdy.21187
[40]	Tang C, Chen W, Luo Y, et al. Runx1 up-regulates chondrocyte to osteoblast lineage commitment and promotes bone formation by enhancing both chondrogenesis and osteogenesis[J]. Biochem J, 2020, 477(13): 2421–2438. doi: 10.1042/BCJ20200036
[41]	Bai Y, Zhang Q, Chen Q, et al. Conditional knockout of the PDK-1 gene in osteoblasts affects osteoblast differentiation and bone formation[J]. J Cell Physiol, 2021, 236(7): 5432–5445. doi: 10.1002/jcp.30249
[42]	Tanaka EM. The molecular and cellular choreography of appendage regeneration[J]. Cell, 2016, 165(7): 1598–1608. doi: 10.1016/j.cell.2016.05.038
[43]	Geurtzen K, Knopf F, Wehner D, et al. Mature osteoblasts dedifferentiate in response to traumatic bone injury in the zebrafish fin and skull[J]. Development, 2014, 141(11): 2225–2234. doi: 10.1242/dev.105817
[44]	Mishra R, Sehring I, Cederlund M, et al. NF-κB signaling negatively regulates osteoblast dedifferentiation during zebrafish bone regeneration[J]. Dev Cell, 2020, 52(2): 167–182.e7. doi: 10.1016/j.devcel.2019.11.016
[45]	Yuh DY, Maekawa T, Li X, et al. The secreted protein DEL-1 activates a β3 integrin-FAK-ERK1/2-RUNX2 pathway and promotes osteogenic differentiation and bone regeneration[J]. J Biol Chem, 2020, 295(21): 7261–7273. doi: 10.1074/jbc.RA120.013024
[46]	Lin Z, He H, Wang M, et al. MicroRNA-130a controls bone marrow mesenchymal stem cell differentiation towards the osteoblastic and adipogenic fate[J]. Cell Prolif, 2019, 52(6): e12688. doi: 10.1111/cpr.12688
[47]	Kang M, Huang CC, Lu Y, et al. Bone regeneration is mediated by macrophage extracellular vesicles[J]. Bone, 2020, 141: 115627. doi: 10.1016/j.bone.2020.115627
[48]	Jiang C, Lin Y, Shan H, et al. miR-146a protects against Staphylococcus aureus-induced osteomyelitis by regulating inflammation and osteogenesis[J]. ACS Infect Dis, 2022, 8(5): 918–927. doi: 10.1021/acsinfecdis.1c00459
[49]	Han L, Wang B, Wang R, et al. The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor[J]. Stem Cell Res Ther, 2019, 10(1): 377. doi: 10.1186/s13287-019-1498-0
[50]	Mobasheri A, Shakibaei M. Osteogenic effects of resveratrol in vitro: potential for the prevention and treatment of osteoporosis[J]. Ann N Y Acad Sci, 2013, 1290(1): 59–66. doi: 10.1111/nyas.12145
[51]	Vidoni C, Ferraresi A, Secomandi E, et al. Autophagy drives osteogenic differentiation of human gingival mesenchymal stem cells[J]. Cell Commun Signal, 2019, 17(1): 98. doi: 10.1186/s12964-019-0414-7
[52]	Yin N, Zhu L, Ding L, et al. MiR-135–5p promotes osteoblast differentiation by targeting HIF1AN in MC3T3-E1 cells[J]. Cell Mol Biol Lett, 2019, 24: 51. doi: 10.1186/s11658-019-0177-6
[53]	Ida-Yonemochi H, Nakagawa E, Takata H, et al. Extracellular enzymatically synthesized glycogen promotes osteogenesis by activating osteoblast differentiation via Akt/GSK-3β signaling pathway[J]. J Cell Physiol, 2019, 234(8): 13602–13616. doi: 10.1002/jcp.28039
[54]	Xiao L, Zhou Y, Zhu L, et al. SPHK1-S1PR1-RANKL axis regulates the interactions between macrophages and BMSCs in inflammatory bone loss[J]. J Bone Miner Res, 2018, 33(6): 1090–1104. doi: 10.1002/jbmr.3396
[55]	Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity[J]. Annu Rev Pathol Mech Dis, 2020, 15: 123–147. doi: 10.1146/annurev-pathmechdis-012418-012718
[56]	Araujo-Pires AC, Vieira AE, Francisconi CF, et al. IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitis[J]. J Bone Miner Res, 2015, 30(3): 412–422. doi: 10.1002/jbmr.2376
[57]	Shi M, Zhang P, Zhao Q, et al. Dual functional monocytes modulate bactericidal and anti-inflammation process for severe osteomyelitis treatment[J]. Small, 2020, 16(4): 1905185. doi: 10.1002/smll.201905185
[58]	Pesce Viglietti AI, Sviercz FA, López CAM, et al. Proinflammatory microenvironment during Kingella kingae infection modulates osteoclastogenesis[J]. Front Immunol, 2021, 12: 757827. doi: 10.3389/fimmu.2021.757827
[59]	Huynh NCN, Everts V, Pavasant P, et al. Interleukin-1β induces human cementoblasts to support osteoclastogenesis[J]. Int J Oral Sci, 2017, 9(12): e5. doi: 10.1038/ijos.2017.45
[60]	Becerra-Ruiz JS, Guerrero-Velázquez C, Martínez-Esquivias F, et al. Innate and adaptive immunity of periodontal disease. From etiology to alveolar bone loss[J]. Oral Dis, 2022, 28(6): 1441–1447. doi: 10.1111/odi.13884
[61]	Wehrhan F, Moebius P, Amann K, et al. Macrophage and osteoclast polarization in bisphosphonate associated necrosis and osteoradionecrosis[J]. J Cranio-Maxillofac Surg, 2017, 45(6): 944–953. doi: 10.1016/j.jcms.2017.02.023
[62]	Yang J, Zhu Y, Duan D, et al. Enhanced activity of macrophage M1/M2 phenotypes in periodontitis[J]. Arch Oral Biol, 2018, 96: 234–242. doi: 10.1016/j.archoralbio.2017.03.006
[63]	Qin S, Li J, Zhou C, et al. SHIP-1 regulates phagocytosis and M2 polarization through the PI3K/Akt-STAT5-Trib1 circuit in pseudomonas aeruginosa infection[J]. Front Immunol, 2020, 11: 307. doi: 10.3389/fimmu.2020.00307
[64]	Guo X, Li T, Xu Y, et al. Increased levels of Gab1 and Gab2 adaptor proteins skew interleukin-4 (IL-4) signaling toward M2 macrophage-driven pulmonary fibrosis in mice[J]. J Biol Chem, 2017, 292(34): 14003–14015. doi: 10.1074/jbc.M117.802066
[65]	Muñoz J, Akhavan NS, Mullins AP, et al. Macrophage polarization and osteoporosis: a review[J]. Nutrients, 2020, 12(10): 2999. doi: 10.3390/nu12102999
[66]	Guo Y, Wang M, Zhang S, et al. Ubiquitin-specific protease USP34 controls osteogenic differentiation and bone formation by regulating BMP2 signaling[J]. EMBO J, 2018, 37(20): e99398. https://pubmed.ncbi.nlm.nih.gov/30181118/
[67]	Zhuang Z, Yoshizawa-Smith S, Glowacki A, et al. Induction of M2 macrophages prevents bone loss in murine periodontitis models[J]. J Dent Res, 2019, 98(2): 200–208. doi: 10.1177/0022034518805984
[68]	Chen X, Wan Z, Yang L, et al. Exosomes derived from reparative M2-like macrophages prevent bone loss in murine periodontitis models via IL-10 mRNA[J]. J Nanobiotechnol, 2022, 20(1): 110. doi: 10.1186/s12951-022-01314-y
[69]	Qiao W, Wong KHM, Shen J, et al. TRPM7 kinase-mediated immunomodulation in macrophage plays a central role in magnesium ion-induced bone regeneration[J]. Nat Commun, 2021, 12(1): 2885. doi: 10.1038/s41467-021-23005-2
[70]	Teng YTA, Nguyen H, Gao X, et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection[J]. J Clin Invest, 2000, 106(6): R59–R67. doi: 10.1172/JCI10763
[71]	Bailly C. The implication of the PD-1/PD-L1 checkpoint in chronic periodontitis suggests novel therapeutic opportunities with natural products[J]. Jpn Dent Sci Rev, 2020, 56(1): 90–96. doi: 10.1016/j.jdsr.2020.04.002
[72]	Taubman MA, Kawai T. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption[J]. Crit Rev Oral Biol Med, 2001, 12(2): 125–135. doi: 10.1177/10454411010120020301
[73]	Le Gros G, Ben-Sasson SZ, Seder R, et al. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells[J]. J Exp Med, 1990, 172(3): 921–929. doi: 10.1084/jem.172.3.921
[74]	Hasiakos S, Gwack Y, Kang M, et al. Calcium signaling in T cells and chronic inflammatory disorders of the oral cavity[J]. J Dent Res, 2021, 100(7): 693–699. doi: 10.1177/0022034521990652
[75]	Castillo F, Monasterio G, Ibarra JP, et al. Levels of low-molecular-weight hyaluronan in periodontitis-treated patients and its immunostimulatory effects on CD4+ T lymphocytes[J]. Clin Oral Investig, 2021, 25(8): 4987–5000. doi: 10.1007/s00784-021-03808-9
[76]	Tyagi AM, Srivastava K, Kureel J, et al. Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss[J]. Osteoporos Int, 2012, 23(3): 1151–1161. doi: 10.1007/s00198-011-1650-x
[77]	Alvarez C, Suliman S, Almarhoumi R, et al. Regulatory T cell phenotype and anti-osteoclastogenic function in experimental periodontitis[J]. Sci Rep, 2020, 10(1): 19018. doi: 10.1038/s41598-020-76038-w
[78]	Zheng Y, Dong C, Yang J, et al. Exosomal microRNA-155–5p from PDLSCs regulated Th17/Treg balance by targeting sirtuin-1 in chronic periodontitis[J]. J Cell Physiol, 2019, 234(11): 20662–20674. doi: 10.1002/jcp.28671
[79]	Donate PB, de Lima KA, Peres RS, et al. Cigarette smoke induces miR-132 in Th17 cells that enhance osteoclastogenesis in inflammatory arthritis[J]. Proc Natl Acad Sci USA, 2021, 118(1): e2017120118. doi: 10.1073/pnas.2017120118
[80]	Tyagi AM, Yu M, Darby TM, et al. The microbial metabolite butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression[J]. Immunity, 2018, 49(6): 1116–1131.e7. doi: 10.1016/j.immuni.2018.10.013
[81]	Mahanonda R, Champaiboon C, Subbalekha K, et al. Human memory B cells in healthy gingiva, gingivitis, and periodontitis[J]. J Immunol, 2016, 197(3): 715–725. doi: 10.4049/jimmunol.1600540
[82]	Wang Y, Liu J, Burrows PD, et al. B cell development and maturation[M]//Wang J. B Cells in Immunity and Tolerance. Singapore: Springer, 2020: 1–22.
[83]	Wang Y, Yu X, Lin J, et al. B10 cells alleviate periodontal bone loss in experimental periodontitis[J]. Infect Immun, 2017, 85(9): e00335–17. doi: 10.1128/IAI.00335-17
[84]	Yu P, Hu Y, Liu Z, et al. Local induction of B cell interleukin-10 competency alleviates inflammation and bone loss in ligature-induced experimental periodontitis in mice[J]. Infect Immun, 2017, 85(1): e00645–16. doi: 10.1128/IAI.00645-16
[85]	Zeng W, Liu G, Luan Q, et al. B-cell deficiency exacerbates inflammation and bone loss in ligature-induced experimental periodontitis in mice[J]. J Inflamm Res, 2021, 14: 5367–5380. doi: 10.2147/JIR.S330875
[86]	Qin Y, Zhang M, Jiang R, et al. B10 cells play a role in the immune modulation of pro- and anti-inflammatory immune responses in mouse islet allograft rejection[J]. Cell Immunol, 2016, 310: 184–192. doi: 10.1016/j.cellimm.2016.09.010
[87]	Han Y, Yu C, Yu Y, et al. CD25+ B cells produced IL-35 and alleviated local inflammation during experimental periodontitis[J]. Oral Dis, 2022, 28(8): 2248–2257. doi: 10.1111/odi.13939
[88]	Zhang Q, Chen B, Yan F, et al. Interleukin-10 inhibits bone resorption: a potential therapeutic strategy in periodontitis and other bone loss diseases[J]. Biomed Res Int, 2014, 2014: 284836. doi: 10.1155/2014/284836
[89]	Krüger-Genge A, Blocki A, Franke RP, et al. Vascular endothelial cell biology: an update[J]. Int J Mol Sci, 2019, 20(18): 4411. doi: 10.3390/ijms20184411
[90]	Yang Y, Li S, Sun X, et al. CCN1 secreted by human adipose-derived stem cells enhances wound healing and promotes angiogenesis through activating the AKT signalling pathway[J]. Int Wound J, 2023, 20(5): 1667–1677. doi: 10.1111/iwj.14028
[91]	Zhao Y, Xie L. Unique bone marrow blood vessels couple angiogenesis and osteogenesis in bone homeostasis and diseases[J]. Ann N Y Acad Sci, 2020, 1474(1): 5–14. doi: 10.1111/nyas.14348
[92]	Diomede F, Marconi GD, Fonticoli L, et al. Functional relationship between osteogenesis and angiogenesis in tissue regeneration[J]. Int J Mol Sci, 2020, 21(9): 3242. doi: 10.3390/ijms21093242
[93]	Pizzicannella J, Gugliandolo A, Orsini T, et al. Engineered extracellular vesicles from human periodontal-ligament stem cells increase VEGF/VEGFR2 expression during bone regeneration[J]. Front Physiol, 2019, 10: 512. doi: 10.3389/fphys.2019.00512
[94]	Ogilvie CM, Lu C, Marcucio R, et al. Vascular endothelial growth factor improves bone repair in a murine nonunion model[J]. Iowa Orthop J, 2012, 32: 90–94. https://pubmed.ncbi.nlm.nih.gov/23576927/
[95]	Kim BS, Yang SS, You HK, et al. Fucoidan-induced osteogenic differentiation promotes angiogenesis by inducing vascular endothelial growth factor secretion and accelerates bone repair[J]. J Tissue Eng Regen Med, 2018, 12(3): e1311–e1324. doi: 10.1002/term.2509
[96]	Maes C, Kobayashi T, Selig MK, et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels[J]. Dev Cell, 2010, 19(2): 329–344. doi: 10.1016/j.devcel.2010.07.010
[97]	Ramasamy SK, Kusumbe AP, Wang L, et al. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone[J]. Nature, 2014, 507(7492): 376–380. doi: 10.1038/nature13146
[98]	Spaderna S, Schmalhofer O, Wahlbuhl M, et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer[J]. Cancer Res, 2008, 68(2): 537–544. doi: 10.1158/0008-5472.CAN-07-5682
[99]	Wellner U, Schubert J, Burk UC, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs[J]. Nat Cell Biol, 2009, 11(12): 1487–1495. doi: 10.1038/ncb1998
[100]	Fu R, Lv W, Xu Y, et al. Endothelial ZEB1 promotes angiogenesis-dependent bone formation and reverses osteoporosis[J]. Nat Commun, 2020, 11(1): 460. doi: 10.1038/s41467-019-14076-3
[101]	Liu X, Li Q, Niu X, et al. Exosomes secreted from human-induced pluripotent stem cell-derived mesenchymal stem cells prevent osteonecrosis of the femoral head by promoting angiogenesis[J]. Int J Biol Sci, 2017, 13(2): 232–244. doi: 10.7150/ijbs.16951
[102]	Jia Y, Zhu Y, Qiu S, et al. Exosomes secreted by endothelial progenitor cells accelerate bone regeneration during distraction osteogenesis by stimulating angiogenesis[J]. Stem Cell Res Ther, 2019, 10(1): 12. doi: 10.1186/s13287-018-1115-7
[103]	Zhou H, Li X, Wu R, et al. Periodontitis-compromised dental pulp stem cells secrete extracellular vesicles carrying miRNA-378a promote local angiogenesis by targeting Sufu to activate the Hedgehog/Gli1 signalling[J]. Cell Prolif, 2021, 54(5): e13026. doi: 10.1111/CPR.13026
[104]	Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise[J]. Cell, 2010, 140(4): 460–476. doi: 10.1016/j.cell.2010.01.045
[105]	Schulte-Merker S, Sabine A, Petrova TV. Lymphatic vascular morphogenesis in development, physiology, and disease[J]. J Cell Biol, 2011, 193(4): 607–618. doi: 10.1083/jcb.201012094
[106]	Poto R, Loffredo S, Palestra F, et al. Angiogenesis, lymphangiogenesis, and inflammation in chronic obstructive pulmonary disease (COPD): few certainties and many outstanding questions[J]. Cells, 2022, 11(10): 1720. doi: 10.3390/cells11101720
[107]	Matilla L, Martín-Núñez E, Garaikoetxea M, et al. Characterization of the sex-specific pattern of angiogenesis and lymphangiogenesis in aortic stenosis[J]. Front Cardiovasc Med, 2022, 9: 971802. doi: 10.3389/fcvm.2022.971802
[108]	Klaourakis K, Vieira JM, Riley PR. The evolving cardiac lymphatic vasculature in development, repair and regeneration[J]. Nat Rev Cardiol, 2021, 18(5): 368–379. doi: 10.1038/s41569-020-00489-x
[109]	Biswas L, Chen J, De Angelis J, et al. Lymphatic vessels in bone support regeneration after injury[J]. Cell, 2023, 186(2): 382–397.e24. doi: 10.1016/j.cell.2022.12.031
[110]	Kim H, Kataru RP, Koh GY. Inflammation-associated lymphangiogenesis: a double-edged sword?[J]. J Clin Invest, 2014, 124(3): 936–942. doi: 10.1172/JCI71607
[111]	Ogata F, Fujiu K, Matsumoto S, et al. Excess lymphangiogenesis cooperatively induced by macrophages and CD4+ T cells drives the pathogenesis of lymphedema[J]. J Invest Dermatol, 2016, 136(3): 706–714. doi: 10.1016/j.jid.2015.12.001
[112]	Shi J, Liang Q, Zuscik M, et al. Distribution and alteration of lymphatic vessels in knee joints of normal and osteoarthritic mice[J]. Arthritis Rheumatol, 2014, 66(3): 657–666. doi: 10.1002/art.38278
[113]	Shen X, Zhu W, Zhang P, et al. Macrophage miR-149–5p induction is a key driver and therapeutic target for BRONJ[J]. JCI Insight, 2022, 7(16): e159865. doi: 10.1172/jci.insight.159865
[114]	Wang H, Chen Y, Li W, et al. Effect of VEGFC on lymph flow and inflammation-induced alveolar bone loss[J]. J Pathol, 2020, 251(3): 323–335. doi: 10.1002/path.5456
[115]	Murakami J, Ishii M, Suehiro F, et al. Vascular endothelial growth factor-C induces osteogenic differentiation of human mesenchymal stem cells through the ERK and RUNX2 pathway[J]. Biochem Biophys Res Commun, 2017, 484(3): 710–718. doi: 10.1016/j.bbrc.2017.02.001
[116]	Fischer V, Haffner-Luntzer M. Interaction between bone and immune cells: implications for postmenopausal osteoporosis[J]. Semin Cell Dev Biol, 2022, 123: 14–21. doi: 10.1016/j.semcdb.2021.05.014
[117]	Breslin JW, Yang Y, Scallan JP, et al. Lymphatic vessel network structure and physiology[J]. Compr Physiol, 2018, 9(1): 207–299. doi: 10.1002/cphy.c180015